1 – 20 of 139
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
A novel quinoline with airway relaxant effects and anti-inflammatory properties
(
- Contribution to journal › Article
-
Mark
Stress Response in Chronic Obstructive Pulmonary Disease - Effect of Cigarette Smoke Extract and Hypoxia on Structural Lung Cells
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2023
-
Mark
Germline variants of the genes involved in NF-kB activation are associated with the risk of COPD and lung cancer development
(
- Contribution to journal › Article
-
Mark
Comorbid conditions as predictors of mortality in severe COPD–an eight-year follow-up cohort study
(
- Contribution to journal › Article
- 2022
-
Mark
Emphysema severity index (ESI) associated with respiratory death in a large Swedish general population
(
- Contribution to journal › Article
-
Mark
Pulmonary Embolism : Ventilation/Perfusion Scintigraphy as a Proper Tool in Diagnosing Pulmonary Embolism and Frequent Pulmonary Comorbidities
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Occupation, socioeconomic status and chronic obstructive respiratory diseases – The EpiLung study in Finland, Estonia and Sweden
(
- Contribution to journal › Article
-
Mark
Dynamically upregulated mast cell CPA3 patterns in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis
(
- Contribution to journal › Article
- 2021
-
Mark
A new protocol for exercise testing in COPD; improved prediction algorithm for WMAX and validation of the endurance test in a placebo-controlled double bronchodilator study
(
- Contribution to journal › Article
-
Mark
Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD : A Prespecified Analysis of The EMAX Trial
(
- Contribution to journal › Article
-
Mark
How to assess breathlessness in chronic obstructive pulmonary disease
(
- Contribution to journal › Article
-
Mark
Severe alpha-1-antitrypsin deficiency increases the risk of venous thromboembolism
(
- Contribution to journal › Article
-
Mark
Fibroblast growth factor 23 is an independent marker of COPD and is associated with impairment of pulmonary function and diffusing capacity
(
- Contribution to journal › Article
-
Mark
The ratio FEV1/FVC and its association to respiratory symptoms—A Swedish general population study
(
- Contribution to journal › Article
-
Mark
Lung Function and Health Status in Individuals with Severe Alpha-1-Antitrypsin Deficiency at the Age of 42
(
- Contribution to journal › Article
-
Mark
Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening : a post hoc analysis of the EMAX trial
(
- Contribution to journal › Article
-
Mark
Hypoxemia severity and survival in ILD and COPD on long-term oxygen therapy – The population-based DISCOVERY study
(
- Contribution to journal › Article
- 2020
-
Mark
Functional Role of Glycosaminoglycans in Decellularized Lung Extracellular Matrix
(
- Contribution to journal › Article
-
Mark
Hypercapnia in advanced chronic obstructive pulmonary disease : A secondary analysis of the national emphysema treatment trial
(
- Contribution to journal › Article
-
Mark
Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators : an analysis of the EMAX randomised controlled trial
(
- Contribution to journal › Article